Standard BioTools Inc. (LAB)

Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.42	166.73	51.7	81.31	28.45	68.52
Short-Term Investments	65.49	126.15	63.19	84.48	-	-
Cash & Short-Term Investments	194.9	292.87	114.9	165.78	28.45	68.52
Cash Growth	-46.80%	154.91%	-30.70%	482.70%	-58.48%	16.85%
Accounts Receivable	13.54	33.41	19.66	17.28	18.32	25.42
Other Receivables	-	0.2	-	-	-	-
Receivables	13.54	33.61	19.66	17.28	18.32	25.42
Inventory	25.42	40.74	20.53	21.47	20.83	19.69
Prepaid Expenses	7.91	8.66	3.13	4.28	4.45	4.01
Restricted Cash	-	-	-	-	0.02	0.02
Total Current Assets	472.44	375.88	158.22	208.82	72.07	117.66
Property, Plant & Equipment	44.19	71.38	54.85	59.54	65.15	55.65
Long-Term Investments	19.49	-	-	-	-	-
Goodwill	-	111.3	106.32	106.25	106.38	106.56
Other Intangible Assets	-	28.95	1.4	13.18	29.18	42.22
Long-Term Deferred Tax Assets	-	-	-	0.23	0.18	-
Other Long-Term Assets	3.52	24.83	2.29	2.3	2.25	2.66
Total Assets	539.64	612.34	323.07	390.31	275.21	324.76
Accounts Payable	6.62	12.28	9.24	7.91	10.6	9.22
Accrued Expenses	22.71	21.61	16.09	7.52	13.59	24.01
Short-Term Debt	-	-	-	-	6.84	-
Current Portion of Long-Term Debt	-	-	59.53	2.08	-	-
Current Portion of Leases	5.11	6.23	4.32	3.68	3.05	2.97
Current Income Taxes Payable	-	-	-	1.44	-	-
Current Unearned Revenue	43.21	16.65	15.22	14.44	15.48	16.39
Other Current Liabilities	30.31	9.13	4.93	6.37	-	1.66
Total Current Liabilities	107.97	65.89	109.33	43.44	49.57	54.25
Long-Term Debt	0.3	0.3	3.98	62.81	64.21	54.22
Long-Term Leases	21.98	26.47	30.37	34.08	37.55	38.18
Long-Term Unearned Revenue	7.4	39.92	14.28	18.18	24.08	29.03
Long-Term Deferred Tax Liabilities	1.14	1.08	0.84	1.06	4.33	8.7
Other Long-Term Liabilities	1.2	6.96	1.07	0.96	0.88	1.33
Total Liabilities	139.98	140.62	159.87	160.52	180.62	185.71
Common Stock	0.4	0.4	0.08	0.08	0.08	0.08
Additional Paid-In Capital	1,726	1,702	860.82	847.01	831.42	815.62
Retained Earnings	-1,280	-1,186	-1,001	-926.1	-736	-676.76
Treasury Stock	-46.47	-46.47	-5.98	-0.56	-	-
Comprehensive Income & Other	-0.48	1.23	-2.22	-1.9	-0.91	0.11
Total Common Equity	399.66	471.72	-148.05	-81.47	94.6	139.05
Shareholders' Equity	399.66	471.72	163.2	229.79	94.6	139.05
Total Liabilities & Equity	539.64	612.34	323.07	390.31	275.21	324.76
Total Debt	27.39	33	98.21	102.66	111.65	95.38
Net Cash (Debt)	167.51	259.88	16.69	63.13	-83.2	-26.86
Net Cash Growth	-39.49%	1457.56%	-73.57%	-	-	-
Net Cash Per Share	0.44	0.74	0.21	0.81	-1.10	-0.37
Filing Date Shares Outstanding	384.57	378.99	290.12	79.06	77.2	74.55
Total Common Shares Outstanding	383.61	377.53	80.23	79.48	76.92	74.54
Working Capital	364.47	309.99	48.89	165.37	22.5	63.41
Book Value Per Share	1.04	1.25	-1.85	-1.02	1.23	1.87
Tangible Book Value	399.66	331.47	-255.77	-200.9	-40.97	-9.74
Tangible Book Value Per Share	1.04	0.88	-3.19	-2.53	-0.53	-0.13
Buildings	-	3.48	1.76	1.71	-	-
Machinery	40.27	68.55	41.8	39.12	38.09	24.34
Construction In Progress	0.38	9.46	2.33	1.61	4.55	9.98
Leasehold Improvements	13.97	17.45	13.79	12.23	12.1	7.2

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q